MENU
MYGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Myriad Genetics (MYGN) Earnings Date & Reports

Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual’s risk of developing a disease... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

MYGN is expected to report earnings to rise ∞% to 0 cents per share on March 03

Myriad Genetics MYGN Stock Earnings Reports
Q4'25
Est.
$0.00
Q3'25
Beat
by $0.01
Q2'25
Beat
by $0.06
Q1'25
Beat
by $0.03
Q4'24
Est.
$0.03
The last earnings report on November 03 showed earnings per share of 0 cents, beating the estimate of 0 cents. With 1.64M shares outstanding, the current market capitalization sits at 592.37M.
View a ticker or compare two or three
MYGN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MYGN showed earnings on November 03, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a developer of therapeutic and predictive medicine products

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Biotechnology
Address
320 Wakara Way
Phone
+1 801 584-3600
Employees
2700
Web
https://www.myriad.com